Pediatric Clinical Trials Market Size, Share, By Phase (Phase I, Phase II, Phase III, and Phase IV), By Study Design (Treatment Studies, and Observational Studies), By Age Group (Infants, Toddlers, Children, and Adolescents), By Therapeutic Area (Oncology, Infectious Diseases, Respiratory Diseases, Rare Diseases, Neurological Disorders, and Other Therapeutic Areas), and By Region - Trends, Analysis and Forecast till 2034

Public-Private Partnerships:

• The alliances between the drug companies, academia, government agencies, and patient advocacy organizations can help in overcoming the challenges to bring innovation in pediatric drug development. It is through such public-private partnerships that access to funding, infrastructure, and expertise is attained, hence translating to new treatments for pediatric diseases. These kinds of partnerships may further make the companies more trustworthy to the patient community, thus improving patient recruitment and better retention.